1-3 of 3
Victoria Ling
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in progress: A Phase IIb randomized clinical trial combining oral azacitidine and vididencel, a novel immunotherapy, for post-remission / maintenance therapy for adult patients with cytogenetically intermediate and high-risk Acute Myeloid Leukemia (ALLG AMLM22/D4 CADENCE)

Free
Victoria Ling, Paula Marlton, John Reynolds, Mark Dawson, Robin Gasiorowski, Hannah Rose, Chun Yew Fong, Jake Shortt, Anoop Enjeti, Carolyn Grove, Joanna Nkyekyer, Nadia Munsef, Andrew Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 5210.
https://doi.org/10.1182/blood-2025-5210
Published: 2025
Journal Articles

Dnmt3a Mutation Promotes Expansion of a Quiescent Myeloid Progenitor Population in Npm1 c -Flt3 ITD Acute Myeloid Leukemia

Free
Paniz Tavakoli, Megan Bywater, Jasmin Straube, Victoria Ling, Emily Cooper, Rohit Haldar, Yashaswini Janardhanan, Leanne Cooper, Claudia Bruedigam, Carolyn S. Grove, Steven W Lane
Journal: Blood
Blood (2024) 144 (Supplement 1): 1347.
https://doi.org/10.1182/blood-2024-201250
Published: 2024
Journal Articles

Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation

Free
Sebastien Jacquelin, Jasmin Straube, Leanne Cooper, Therese Vu, Axia Song, Megan Bywater, Eva Baxter, Matthew Heidecker, Brad Wackrow, Amy Porter, Victoria Ling, Joanne Green, Rebecca Austin, Stephen Kazakoff, Nicola Waddell, Luke B. Hesson, John E. Pimanda, Frank Stegelmann, Lars Bullinger, Konstanze Döhner, Raajit K. Rampal, Dirk Heckl, Geoffrey R. Hill, Steven W. Lane
Journal: Blood
Blood (2018) 132 (26): 2707–2721.
https://doi.org/10.1182/blood-2018-04-846220
Published: 2018
Includes: Supplemental data